A window into new drug development for urologic oncology. Part I: How bench-to-bedside research can result in approval

Haas Gabriel P.; Scher Howard I.

首页> 外文期刊>Urologic oncology >A window into new drug development for urologic oncology. Part I: How bench-to-bedside research can result in approval

【24h】

A window into new drug development for urologic oncology. Part I: How bench-to-bedside research can result in approval

机译：泌尿外科肿瘤学新药开发的窗口。第一部分：逐项研究如何获得批准

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Urologic oncology》 |2015年第3期|共1页
作者
Haas Gabriel P.; Scher Howard I.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. A window into new drug development for urologic oncology. Part I: How bench-to-bedside research can result in approval [J] . Haas Gabriel P., Scher Howard I. Urologic oncology . 2015,第3期

机译：泌尿外科肿瘤学新药开发的窗口。第一部分：逐项研究如何获得批准
2. A window into new drug development for urologic oncology. Part II: Bench-to-bedside research improves survival in urologic cancer, and the discovery of better biomarkers can help predict patient response, toxicity, and resistance to therapy [J] . Haas Gabriel P., Scher Howard I. Urologic oncology . 2015,第6期

机译：泌尿外科肿瘤学新药开发的窗口。第二部分：逐项研究提高了泌尿外科癌症的生存率，发现更好的生物标志物可以帮助预测患者的反应，毒性和对治疗的抵抗力
3. Food and Drug Administration process for development and approval of drugs and radiopharmaceuticals: Treatments in urologic oncology [J] . Ning Yang-Min, Maher V. Ellen Urologic oncology . 2015,第3期

机译：食品药品监督管理局药品和放射性药物开发和批准程序：泌尿科肿瘤学治疗
4. A swellable drug-eluting ureteral stent for the treatment of urological diseases [C] . Wei Shan Lim, Yingying Huang, Tsung Wen Chong, Society for Biomaterials annual meeting and exposition . 2017

机译：用于治疗泌尿系统疾病的可溶胀药物洗脱输尿管支架
5. Meta-Analysis to Identify and Evaluate Factors Associated with Regulatory Approval of Orphan Drugs (OD) to Develop an Algorithm for Predicting Regulatory Approval (Success) and to Develop a Standardized Tool to Improve Orphan Drug Portfolio Decision-Making [D] . Florent, Milky C. 2019

机译：荟萃分析，以识别和评估与孤儿药物监管批准（OD）相关的因素，以开发预测监管批准（成功）的算法，并开发标准化工具以改善孤儿药物投资组合决策
6. Usage of invisible near infrared light (NIR) fluorescence with indocyanine green (ICG) and methylene blue (MB) in urological oncology. Part 1 [O] . Wojciech Polom, Marcin Markuszewski, Young Soo Rho, 2014

机译：在泌尿科肿瘤学中使用不可见的近红外光（NIR）荧光和吲哚菁绿（ICG）和亚甲基蓝（MB）。第1部分
7. First Approval of Improved Medical Device Conditional on Use-Result Survey in Japan ― Regulatory Review of Polymer-Free Drug-Coated BioFreedom Coronary Stent ― [O] . Akihide Konishi, Mami Ho, Yuko Shirai, 2018

机译：改进医疗器械条件的首次批准日本使用结果调查 - 无菌药物涂层生物葡萄葡萄酒支架的监管综述 -

A window into new drug development for urologic oncology. Part I: How bench-to-bedside research can result in approval

著录项

相似文献

相关主题

期刊订阅